Keep cool: Germany preps vaccine drive as COVID cases hit 1M

  • An employee of Binder, the world's largest manufacturer of serial-production environmental simulation chambers for laboratories, checks an ultra low temperature freezer Tuesday in Tuttlingen, Germany. (AP Photo/Matthias Schrader, file)

TUTTLINGEN, Germany — Hulking gray boxes are rolling off the production line at a factory in the southern town of Tuttlingen, ready to be shipped to the front in the next phase of Germany’s battle against the coronavirus as it became the latest country to hit the milestone of 1 million confirmed cases Friday.

Man-sized freezers such as those manufactured by family-owned firm Binder GmbH could become a key part of the vast immunization program the German government is preparing to roll out when the first vaccines become available next month.


That’s because one of the front-runners, a vaccine made by German company BioNTech together with U.S. pharmaceutical giant Pfizer, needs to be cooled to minus 70 degrees Celsius (minus 94 degrees Fahrenheit) for shipping and storage.

Ensuring such temperatures, colder even than an Antarctic winter, is just one of the many challenges that countries face in trying to get their populations immunized.

The effort has been compared to a military operation. Indeed some countries, including Germany, are relying on military and civilian expertise to ensure the precious doses are safely transported from manufacturing plants to secret storage facilities, before being distributed.

Germany has benefited from the market power that comes with being a member of the European Union. The 27-nation bloc’s executive Commission — led by former German Defense Minister Ursula von der Leyen — has spearheaded negotiations with vaccine makers, ordering more than a billion doses so far.

German officials have said the country hopes to secure up to 300 million doses from the EU orders and bilateral deals with three manufacturers in Germany, including BioNTech and CureVac, a company based in Tuebingen that says its vaccine can be stored at regular refrigerator temperatures for up to three months. Its trials are not as far along, however, as Pfizer/BioNTech and others.

The figure of 300 million is contingent on all vaccines being developed making it to market. That would be more than enough to immunize Germany’s population of 83 million, even if two shots are required, as seems likely.

How exactly the vaccine is delivered to patients differs from country to country. In Germany, the federal government has delegated the task to its 16 states, which are now working to build large vaccination centers.

The city-state of Berlin has drafted in Albrecht Broemme, a veteran of disaster management. The former Berlin fire chief later led Germany’s federal civil protection organization THW, where he helped organize disaster relief operations for floods, storms and quakes around the world.


The 67-year-old is now coordinating the setting-up of six vaccine hubs in Berlin in a convention center, two former airports, an ice skating rink, a concert hall and an indoor cycle race track.

Authorities want them ready by mid-December to begin vaccinating more than 3,000 people per day at each location. With just a few minutes to deliver each shot and mindful of keeping the number of people in each center at a minimum, Broemme and his colleagues are devising a one-way flow system similar to that found in large stores like furniture company Ikea.

Leave a Reply

Your email address will not be published. Required fields are marked *


By participating in online discussions you acknowledge that you have agreed to the Star-Advertiser's TERMS OF SERVICE. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. To report comments that you believe do not follow our guidelines, email